COVID-19 Medication Limits

In response to COVID-19, the Texas State Board of Pharmacy issued a new medication limits rule to help ensure access to specific medications, like chloroquine, hydroxychloroquine, mefloquine or azithromycin. When writing prescriptions, physicians should:

  • Prescription must have a written diagnosis consistent with evidence for its use.
  • Number of doses is limited to no more than a fourteen (14) day supply.
    • HM strongly recommends limiting quantity to what is needed for completion of therapy following discharge.
  • No refills permitted.
  • For more information:

The FDA issued an Emergency Use Authorization (EUA) for chloroquine phosphate and hydroxychloroquine sulfate, currently recommended in several countries for treatment of hospitalized COVID-19 patients. The EUA will help facilitate chloroquine phosphate and hydroxychloroquine sulfate availability during the COVID-19 pandemic for treating patients who can’t participate in a clinical trial.

For more information, read the FDA – Emergency Use Authorization for chloroquine and hydroxychloroquine sulfate in the treatment of COVID-19 patients.

If you need help obtaining hydroxychloroquine for a discharging patient, contact your entity hospital pharmacy.